the current regulatory status of proms for clinical trials in migraine
Published 2 years ago • 26 plays • Length 1:59Download video MP4
Download video MP3
Similar videos
-
1:12
the micoas project in migraine
-
1:30
future work on rimegepant for migraines
-
3:09
open-label extension study of rimegepant for acute and preventive migraine treatment
-
3:26
zavegepant: an acute treatment option for migraine
-
50:14
methods matters | patient-reported outcome measures (proms) for falls prevention
-
5:04
patient reported outcomes measures (proms): uses in healthcare
-
4:52
what are patient reported outcomes measures (proms)?
-
39:55
advancing the science and use of patient-reported outcome measures (proms)
-
6:15
patient-reported outcome measures (proms): implementation of proms
-
5:15
the current status of pre-exposure prophylaxis for covid-19 in immunocompromised patients
-
1:24:53
peer-learning pills: development of patient reported outcome measures (proms)
-
0:51
active surveillance vs. watchful waiting
-
1:04
international medical device regulators forum (imdrf) australia 2022 launch.
-
6:12
aci - patient reported measures
-
0:52
extended follow-up of ambassador: adjuvant pembrolizumab in miuc
-
3:07
the statewide patient reported measures program
-
4:26
proms (patient reported outcome measures) explained by ent surgeon dr tom stewart
-
6:18
updates of changes in the early detection of prostate cancer nccn guidelines 2021